Comment
doi: 10.1136/annrheumdis-2018-214908.
Epub 2019 Jan 4.
'To switch or not to switch': the missing piece in the puzzle of biosimilar literature?
Affiliations
- PMID: 30610068
- DOI: 10.1136/annrheumdis-2018-214908
Item in Clipboard
Comment
'To switch or not to switch': the missing piece in the puzzle of biosimilar literature?
Ann Rheum Dis.
2020 Apr.
No abstract available
Keywords: DMARDs (biologic); TNF-alpha; patient perspective; rheumatoid arthritis.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to ''To switch or not to switch': the missing piece in the puzzle of biosimilar literature?' by Scherlinger et al.Ann Rheum Dis. 2020 Apr;79(4):e37. doi: 10.1136/annrheumdis-2018-214952. Epub 2019 Jan 23. Ann Rheum Dis. 2020. PMID: 30674476 No abstract available.
Comment on
-
To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry.Ann Rheum Dis. 2019 Feb;78(2):192-200. doi: 10.1136/annrheumdis-2018-213474. Epub 2018 Nov 5. Ann Rheum Dis. 2019. PMID: 30396903
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
